Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Ovarian Neoplasms 32 Triple Negative Breast Neoplasms 19 Prostatic Neoplasms 17 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 14 Pancreatic Neoplasms 9 Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Glioma 6 Stomach Neoplasms 5 Sarcoma 5 Lung Neoplasms 5 Glioblastoma 5 Squamous Cell Carcinoma of Head and Neck 4 Metastatic Castration-resistant Prostate Cancer 4 Carcinoma, Ovarian Epithelial 4 Solid Tumors 3 Recurrence 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Urinary Bladder Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms, Castration-Resistant 2

Interventions

Radiosurgery 50 Magnetic Resonance Spectroscopy 34 Temozolomide 28 Bevacizumab 24 pembrolizumab 23 Radiotherapy 20 Nivolumab 20 Specimen Handling 14 Ipilimumab 13 Cyclophosphamide 13 Mental Status and Dementia Tests 12 Carboplatin 12 abemaciclib 10 Radiation 10 trastuzumab deruxtecan 8 Proton Therapy 7 Pemetrexed 7 Memantine 7 Blood Specimen Collection 7 fluciclovine F-18 6 binimetinib 6 Paclitaxel 6 Lomustine 6 Etoposide 6 Cisplatin 6 Capecitabine 6 encorafenib 5 Trastuzumab 5 Surveys and Questionnaires 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × olaparib × 1 year × Clear all

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡